US drug company Pfizer has appointed CB Richard Ellis to sell its 325-acre research and development site in Kent.
Pfizer said it intended to have fully exited the site, in Sandwich, by the end of 2012. The
US drug company Pfizer has appointed CB Richard Ellis to sell its 325-acre research and development site in Kent.
Pfizer said it intended to have fully exited the site, in Sandwich, by the end of 2012. The
Our mission is to support you in finding and assessing investment and development opportunities faster.
Help us do just that by taking part in an exclusive product testing session.
Sign up nowKind regards,
The EG team